7
Participants
Start Date
April 30, 2008
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
Placebo
Days 1 - 3 (0.5 mg tablet, q.d.), Days 4 - 7 (0.5 mg tablet, b.i.d.), and Day 8 - 21 (1 mg tablet, b.i.d.).
Varenicline
Days 1 - 3 (0.5 mg tablet, q.d.), Days 4 - 7 (0.5 mg tablet, b.i.d.), and Day 8 - 21 (1 mg tablet, b.i.d.).
Tobacco Use Research Center, Minneapolis
Collaborators (1)
National Institute on Drug Abuse (NIDA)
NIH
Pfizer
INDUSTRY
University of Minnesota
OTHER